section name header

Pronunciation

proe-klor-PAIR-a-zeen audio

Indications

BEERS REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Absorption from tablet is variable; may be better with oral liquid formulations. Well absorbed after IM administration.

Distribution: Widely distributed, high concentrations in the CNS. Crosses the placenta and probably enters breast milk.

Protein Binding: ge.gif90%.

Metabolism/Excretion: Highly metabolized by the liver and GI mucosa. Converted to some compounds with antipsychotic activity.

Half-life: Unknown.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

EENT: blurred vision, dry eyes, lens opacities.

CV: ECG changes, hypotension, tachycardia.

GI: constipation, dry mouth, anorexia, drug-induced hepatitis, ileus.

GU: pink or reddish-brown discoloration of urine, urinary retention.

Derm: photosensitivity, pigment changes, rashes.

Endo: galactorrhea.

Hemat: AGRANULOCYTOSIS, leukopenia.

Metab: hyperthermia.

Neuro: NEUROLEPTIC MALIGNANT SYNDROME, extrapyramidal reactions, sedation, tardive dyskinesia.

Misc: allergic reactions.

Interactions

Drug-Drug:

Drug-Natural Products:

Route/Dosage

see Calculator

Pediatric dose should not exceed 10 mg on the 1st day and then should not exceed 20 mg/day in children 2–5 yr or 25 mg/day in children 6–12 yr

Antiemetic

Antipsychotic

Antianxiety

Implementation

US Brand Names

Compazine, Compro

Canadian Brand Names

Prochlorazine

Classifications

Therapeutic Classification: antiemetics, antipsychotics

Pharmacologic Classification: phenothiazines

Availability

(Generic available)

Time/Action Profile

(antiemetic effect)

ROUTEONSETPEAKDURATION
PO30–40 minunknown3–4 hr
Rect60 minunknown3–4 hr
IM10–20 min10–30 min3–4 hr
IVrapid (min)10–30 min3–4 hr

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*